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Recently we reported that the high-affinity receptor for 19B, 
FCERI, is constitutively expressed on normal epidermal Lan-
gerhans cells (LC) and on certain cells within the dermis. To 
study the nature of these cells we performed immunofluores-
cence double-labeling experiments using an anti-FcERI re-
agent (MoAb 15-1) as well as monoclonal antibodies (MoAb) 
against leukocyte differentiation antigens expressed on LC, 
interdigitating cells and macrophages. Avidin-fluorescein 
isothiocyanate was used to distinguish mast cells. 
We found that dermal FCERI+ cells are bone marrow de-
rived (CD45+). Further, we found that a subset of 15- 1+ 
dermal cells coexpresses antigens present on certain members 
of the LC/DC family: the majority of FCERI+ cells reacted 
with MoAb anti-HLA-DR and RFD1, the latter recognizes 
an antigenic moiety on interdigitating cells, and a small sub-
population coexpressed CD la. In reverse fashion, virtually 
R ecently, we and others [1-3] showed that the high-af-finiry receptor for IgE (FCERI) is constitutively ex-pressed on epidermal Langerhans cells (LC) and on certain cells in the dermis that are preferentially lo-cated in close proximity to the microvasculature. 
Some of these cells showed reactiviry with fluorescein isothiocyan-
ate (FITC) -labeled avidin and were therefore identified as mast 
cells [4]. However, a considerable portion of FCERI+ dermal cells 
exhibited immunomorphologic features that argued against a mast 
cells nature, i.e., they were highly dendritic and failed to react with 
avidin-FITC. 
We therefore considered the possibiliry that a portion of FCERI+ 
dermal dendritid cells could be related to cells of the LC/dendritic 
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* If not stated differently, we use the term "dendritic" in this study as 
description of cell morphology independent of its function. 
all CDla+ cells and most RFD1+ cells reacted with the anti-
FCERI rea~e.nt. Approximately one third of 15-1 + cells repre-
sented aVldm-FITC+ mast cells whereas FCERI expression 
was not detected on FXIIIa+ dermal dendrocytes or CD3+ 
lympho~ytes. By immunoelectronmicroscopy, we found 
that penvascularly located 15-1-reactive cells exhibited pro-
nounced dendrites, an indented nucleus, numerous mito-
chondria, and abundant endo-/lysosomal structures. How-
ever, Birbeck granules or granules specific for basophils or 
eosinophils were never detected in these cells. 
Collectively, our data suggest that the pool of dermal 
FCERI+ cells consists mainly of cells of the LC (CDla+)/ 
DC(RFD1+) lineage and mast cells but does not include 
FXIIIa+ dermal macrophages. ] Invest Dermatol 102:315-
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cell (DC) lineage [5] or to the population of factor XIIIa+ (FXIIla) 
dermal dendrocytes that are thought to belong to the mononuclear 
phagocyte system [6 - 8] or, even, to non-hematopoietic dendritic 
cells. To address this issue, we performed immunoelectronmicro-
scopic studies using the monoclonal antibody (MoAb) 15-1 directed 
against the a-chain of the FCERI (FcERla) as well as immunofluo-
rescence double-labeling experiments using MoAb 15-1 versus a 
panel of antibodies directed against several leukocyte differentiation 
antigens. 
MATERIALS AND METHODS 
Specimen Collection Specimens of clinically normal-appearing perile-
siona! skin from various anatomical sites were obtained from 10 patients 
undergoing incisional or excisional biopsies for inflammatory or neoplastic 
skin conditions. 
Preparation of Tissue For light microscopic immunolabeling studies, 
pieces of fresh skin were embedded in Tissue-Tek II OCT (Miles Laboratory 
Inc., Elkhart, IN), frozen in isopentane cooled in a bath of liquid nitrogen, 
and stored at - 20' C. Four-micrometer cryostat sections were cut and 
mounted on poly-L-Iysine-coated (Sigma, St. Louis, MO) slides. The slides 
were air-dried, fixed in cold (4 ' C) acetone for 10 min, and stored at - 20 ' C 
until use. 
For ultrastructural investigations, skin biopsy specimens were cut into 
small cubes and immediately fixed in paraformaldehyde-Iysine-periodate for 
5 h at room temperature (RT) [9). The tissue was then transferred to phos-
phate-buffered saline (PBS)/lO% dimethylsulfoxide (DMSO) and incu-
bated for 1 h at 20'C, before being snap frozen and stored in liquid nitro-
gen. 
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Figure 1. Demonstration of FceRIa+ on dermal mast cells. Cryostat sections were reacted with MoAb 15-1/Texas Red and counterstained with avidin-
FITC. Single photographic exposure of an identical field with the appropriate filtershows.F~eRI~+ cells in red (A) an? avidin-FITC+ cells in gre.en (B) . 
Double photographic exposure reveals that some dermal cells appear yellow due to their reactivity with MoAb 15-1 and aVldm-FITC (C), demonstratmg that 
these cells are FceRIa+ mast cells. Bar, 24 f.Lm. 
Antibodies Primary antibodies used are listed in Table J. 
Immunoperoxidase Single-Labeling Procedure After exposure to 
10% sheep serum and 1% human AB serum for 40 min at RT, cryostat 
sections were incubated overnight with MoAb 15-1 at 4· C. Sections were 
then consecutively incubated with biotinylated-sheep-F(ab'), anti - mouse-
Ig (0.6 f.Lg/ml, Amersham Int., Little Chalfont, UK) for 1 h, with avidin-
biotin complex (ABC) as indicated by the manufacturer (Dako A/S, Glos-
trup, Denmark), with 3-amino-9-ethylcarbazole (Sigma) in 0.05 M acetate 
buffer, pH 5.0, for 5-15 min and, finally, counterstained with hematoxy-
lin. 
Immunofluorescence Double-Labeling Procedures After exposure 
to 10% sheep serum for 1 h at RT, cryostat sections were incubated over-
night at 4'C with one of the primary MoAb (15-1, KiM8, or IOT6c; all 
mouse IgG t). To visualize the bound MoAb, sections were further incubated 
with biotinylated goat- anti-mouse-IgGt (0.6 f.Lg/ml, Amersham) for 1 hat 
RT, followed by an incubation with Texas-Red-labeled streptavidin (2.5 
f.Lg/ml, Amersham) for 1 hat RT. Sections were then subjected to one of the 
following counterstaining protocols: a) overnight exposure to FITC-labeled 
MoAb (see Table I) at 4'C after pre-incubation with 10% normal mouse 
serum for 40 min; b) incubation with polyclonal rabbit antibody against 
FXIIIa or CD3 (epsilon chain) overnight at 4 ' C followed by F1TC-labeled 
swine-anti-rabbit (1: 100, Dako A/S) for 1 hat RT; c) incubation with 
MoAb RFDl or LeuMl (both mouse IgM) overnight at 4'C followed by 
FITC-labeled rat-anti-mouse IgM, 1 f.Lg/ml (Southern Biotechnology As-
sociates, Inc., Birmingham, AL); d) incubation with F1TC-conjugated avi-
din for 2 h at RT to identify mast cells (1 : 50, Zymed Laboratories Inc., San 
Francisco, CAl [4]. 
This basic staining protocol was modified in certain instances to enhance 
the staining intensity. a) In most experiments biotinylated sheep-F(ab')2-
anti-mouse-Ig (0.6 f.Lg/ml, Amersham) was used in addition to goat-anti-
mouse-IgG t as second-step antibody. b) The incubation chain for visualiza-
tion of primary mouse antibody was prolonged by the following consecutive 
incubation steps: biotinylated mouse-IgGt-control-MoAb (1 f.Lg/ml, 
Coulter Immunology, Hialeah, FL) for 40 min at RT, biotinylated goat-
anti-mouse-IgG t (0.6 f.Lg/ml, Amersham) for 40 min at RT and, finally, 
with Texas Red-labeled streptavidin (2.5 f.Lg/ml, Amersham) for 40 min at 
RT. c) F1TC-counterstaining was enhanced by the exposure of cryostat 
Table I. Primary Antibodies Used 
Antibody Specificity 
15-1 FceRIa 
HLe-1 CD45 
Anti-HLA-DR HLA-DR 
OKT6 CDla 
IOT6 CDla 
IOT6c CD1c 
RFD1 interdigitating ce\1s 
Anti-FxIIla FXIIIa 
KiM8 macro phages 
LeuMl CD15 
Anti-CD3 CD3 (epsilon chain) 
Leu12 CD19 
Species/Iso type 
Mouse/IgGt 
Mouse/IgG t 
Mouse/IgG:z. 
Mouse/IgGt 
Mouse/IgGt 
Mouse/IgG t 
Mouse/IgM 
Rabbit polyclonal Ab 
Mouse/IgG t 
Mouse/IgM 
Rabbit polyc1onal Ab 
Mouse/IgG t 
Label 
F1TC 
F1TC 
FITC 
FITC 
Working Concentration/ 
Dilution 
1.4 f.Lg/ml 
0.5f.Lg/ml 
0.3f.Lg/ml 
2.5 f.Lg/ml 
0.2J.lg/ml 
10f.Lg/ml 
1 : 10 
1 : 800 
0.2f.Lg/ml 
0.5 f.Lg/m1 
5f.Lg/ml 
2.5f.Lg/ml 
Source' 
J.P. Kinet [1] 
B.D. 
B.D. 
Ortho 
Immunotech 
Immunotech 
L.W. Poulter [9] 
Behring 
Behring 
B.D. 
Dako A/S 
B.D . 
'B. D., Becton Dickinson (Mountain View, CAl; Ortho (Raritan, NJ); Immunotech (Marseille, France); Behring, Behringwerke (Marburg/Lahn, Germany); DakoA/S (Glostrup, 
Denmark). 
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Table II. Expression of Various Leukocyte Differentiation 
Antigens on FCERIa+ Dermal Cells· 
CD4S 
HLA-DR 
Avidin-FITC 
CDla 
Anti-RFDl 
FXIIIa 
CD3 
98% ± S% 
84% ± 13% 
3S% ± 21 % 
14% ± 8% 
72% ± 23% 
O%b 
0% 
• Percentage ± SD positive cells out of all FceRla+ cells. 
! In about 5% of FXlIIa+ cells the lack of expression of FceRIa was ambiguous. 
sections to rabbit-anti-FITC (1: 100, Dako A/S) for 1 hat RT, followed by 
an incubation with FITC-labeled swine-anti-rabbit (1: 100, Dako A/S) for 
1 hat RT. 
All staining reagents were diluted in PBS containing S% milk proteins. 
Sections were incubated in a humidified environment. Tris-buffered saline 
(TBS), pH 7.4, was used as rinsing buffer after each incubation step. After the 
last incubation step the preparations were covered with polyvinyl alcohol 
(Hoechst, Frankfurt/Main, Germany) and examined using a microscope 
(Nikon, Tokyo, Japan) with epifluorescent illumination and selective filters 
for FITC and Texas Red. Controls were performed by the substitution of 
primary antibody and/or antibody of the counterstaining procedure with the 
appropriate isotype control antibody, or with normal rabbit serum. In no case 
were signals above background levels detected. 
The density of positive cells was determined in 8 -1 0 sequential fields of 
the mid and upper dermis at a 400X magnification (total area equivalent to 
2.4-3.0 mm2) . The data were then calculated for an area of 1 mm2• By 
counting the total number of cells positive for each antibody and those that 
were double-labeled, the proportion of cells bearing both markers were 
quantified. 
In1munoelectronmicroscopy Studies Ten- to fifteen-micrometer cry-
ostat sections of paraformaldehyde-Iysine-periodate- fixed tissue were sub-
jected to an immunogold staining procedure using a pre-embedding method 
as described previously [11]. Briefly, sections were quenched in phosphate-
buffered saline (PBS)/l % egg albumin (Sigma)/O.OOS% saponin (Sigma) 
and then incubated with MoAb lS-1 (14 Jig/m] in PBS/O.l % egg albumin/ 
O.OOS% saponin) for 12 h at 4°C. After washing, the sections were reacted 
with a 1: S diluted goat-anti-mouse IgG-gold conjugate (S nm; Amer-
sham), washed, and fixed with 1.S% glutardialdehyde in 0.1 M cacodylate 
buffer, pH 7.4. After incubation in verona] acetate-buffered osmium and 
O.S% aqueous uranylacetate, the sections were dehydrated and embedded in 
Epon 812. In control experiments, the MoAb lS-l was replaced by an 
appropriate isotype antibody. Ultrathin sections were cut using an 
"Ultracut" ultramicrotome (Reichert Scientific Instruments, Buffalo, 
NY) and examined with an electron microscope (1200 XL; Jeol, Tokyo, 
Japan) . 
RESULTS AND DISCUSSION 
In the present study, we investigated the immunophenotypic and 
morphologic features of FCERIa-bearing cells within the human 
dermis, aiming to clarify their ontogenetic derivation and to define 
their relationship to different cell lineages. In a first series of experi-
ments, we confirmed our previous findings [1] i) that MoAb 15-1, 
directed against the a-chain of FCERI, reacts with dendritic cells in 
the dermis, ii) that these FCERIa+ cells are predominantly located in 
the papillary dermis in close proximity to the capillaries of the 
superficial vascular plexus, and iii) that approximately one third 
(35% ± 21 %) of all dermal FCERla+ cells, particularly those located 
in the deeper part of the tissue, react with avidin-FITC, and thus, 
represent mast cells [4] (Fig 1). Although approximately one third 
(33% ± 31 %) of all avidin-FITC+ mast cells displayed clear 15-1 
immunoreactivity, the majority of the cells showed only faint and, 
sometimes, barely visible 15-1 positivity. On a quantitative basis, 
FCERla-bearing cells of the mid and upper dermis were now found 
to exhibit a density of 32 ± 9 positive cells/mm2• 
To unravel the nature of the FCERla+ non-mast cells within 
the human dermis, we performed immunofluorescence double-
labeling experiments using a panel of lineage specific antibodies 
(Table I). 
The results obtained (Table II) showed that virtually all (98% ± 
5%) FCERla+ cells in the dermis express CD45, which proves their 
bone marrow origin [12] . 
Figure 2. Demonstration of CD la on a portion ofFceRIa+ dermal cells. Cryostat sections were reacted with MoAb lS-1 / Texas Red and counterstained with 
MoAb OKT6-FITC. Single photographic exposure of an identical field with the appropriate filter shows FceRla+ cells in red (A) and CDla+ cells in green 
(B) . Double photographic exposure reveals that some dermal cells appear yellow or orange due to their reactivity with MoAb lS-l and MoAb OKT6 (C) , 
indicating that dermal LC express FceRIa. Bar, 24 Jim. 
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Figure 3. Demonstration ofRFD 1-reactive moieties on a major portion of FceRla+ dermal cells. Cryostat sections were reacted with MoAb 15-1/Tcxas Red 
and counterstained with MoAb RFD1/FITC. Single photographic exposure of an identical field with the appropriate filter shows FceRla+ cells in red (A) and 
RFD1+ cel ls in green (B) . Double photographic exposure reveals that the majority of dermal cells appear orange due to their reactivity with MoAb 15-1 and 
MoAb RFDI (C), indicating that cells of the LC/DC lineage express FceRla. Bar, 49 f.lm. 
Our further observations i) that CD3 antigens and FCERla are 
expressed on mutually exclusive cell populations and ii) that the 
human dermis is devoid of CD19+ and CD15+ cells, lead us to 
conclude that neitil.er T cells, B cells, nor granulocytes [13] signifi-
cantly contribute to the pool of FCERIa+ dermal cells. 
To investigate the relationship between FCERIa+ dendritic cells 
of the upper dermis and cells of the LC/DC-lineage, we performed 
immunofluorescence experiments using MoAb 15-1 versus either 
MoAb OKT6 (anti-CDla) expressed on resident LC [14], RFD1 
expressed on interdigitating cells of the LC/DC lineage [10], or 
anti -HLA-DR expressed on all cells of the LC/DC lineage [15] . 
Results obtained (Table II) showed that 14% ± 8% of all 15-1 + cells 
expressed CD1a (Fig 2) and, conversely, that most (82% ± 21 %) 
CD1a+ cells display 15-1 reactivity. Further, we found that the vast 
majority of FCERIa+ dermal cells express both HLA-DR (84% ± 
13%) and RFD1-reactive moieties (72% ± 23%) (Fig 3) indicating 
that most FCERIa+ cells belong to the LC/DC lineage. In reverse 
fashion, approximately two thirds (70% ± 13%) of all RFD 1 + cells 
Figure 4. FceRla+ cells and FXllIa+ cells are mutually exclusive cell populations. Cryostat sections were reacted with MoAb 15-1 visualized with Texas Red 
and with rabbit antibody against FXIIIa visualized with FITC. Single photographic exposure of an identical field with the appropriate filter shows FCERla + 
cells in red (A) and FXlIIa+ cells in green (B). Double photographic exposure reveals that red and green cells show essentially no overlap (C), indicating that 
FXIIla+ macrophages do not express FCERla. Bar, 49 f.lm. 
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Table III. Leukocyte Differentiation Antigens Expressed on 
Cells of the LC/DC-Lineage (percentage ± SD) 
Dermal LC 
(CDla+) 
100% ± 1% CD1c+ 
all cells RFD1+ (n = 3) 
Indeterminate Cells 
(CDlc+) 
27% ± 23% CD1a+ 
76%±17%RFD1+ 
Interdigitating Cells 
(RFD1+) 
17% CD1a+ (n = 3) 
39% ± 14% CD1c+ 
expressed FCERIa. Our further observations (Table III) that i) all 
CD1a-bearing dermal dendritic cells co express CD1c (an antigen 
found on indeterminate cells, defined as cutaneous, dendritic non-
keratinocytes lacking Birbeck granules, melanosomes, or Merkel 
cell granules [16]), and moieties recognized by MoAb RFD1, and ii) 
that CD1c-expressing and RFD1-expressing cell populations are 
largely overlapping, implies that most, if not all, dermal cells of the 
LC/DC lineage express FCERIa. However, it should be mentioned 
that CD 1 a/ CD 1 c expression by FCERIa+ cells is not an unequivocal 
proof for their affi liation to the LC/DC lineage because recent in 
vitro studies [17 -19] showed that CD1 can be expressed by periph-
eral blood monocytes cultivated in the presence of GM-CSF [17], 
GM-CSF and IL-4 [1 8], or low concentrations of fetal bovine serum 
(FBS) [19] . 
To clarify the relationship between FCERIa+ cells and mononu-
clear phagocytes we performed double-labeling experiments using 
MoAb 15-1 and rabbit antibody directed against FXIIIa expressed 
by dermal dendrocytes [6-8]. On the basis of their phenotypic 
profile (CD36+, CD11b+, CD14+, CD1- [6,7], CD68+ [8]), these 
cells are considered to belong to the mononuclear phagocyte lin-
eage. Our results showed that the expression of FCERIa and FXIIIa 
is mutually exclusive (Fig 4). Together with the finding that most 
(91 % ± 13%) of the FXIIIa+ cells react with the pan-macrophage 
marker KiM8 [20,21] (Table IV) this observation implies that a 
substantial portion of dermal macrophages are devoid of immuno-
histologically detectable FCERIa moieties. Unfortunately, we could 
not directly address this issue because the MoAb, KiM8 and 15-1, 
are both of the IgG I isotype and can therefore not successfully be 
used for double-staining purposes. We found, however, that 
50% ± 25% of all RFD1+ cells in the dermis react with MoAb 
KiM8 (Table IV) . Based on the fact that most RFD1+ dermal cells 
display 15-1 reactivity (see above) one must therefore assume that at 
least a subpopulation of the KiM8+ /RFD 1 + cells express FCERIa. 
Although the reactivity with KiM8 is compatible with the view that 
this FCERIa+ subpopulation belongs to the macrophage family, our 
recent finding ofKiM8 expression on CD1a+ epidermal and dermal 
cells (Osterhoff et ai, unpublished observations) questions the selec-
tivity of KiM8 as macrophage marker and opens the possibility for 
the existence of a RFD1+/CDla-/KiM8+ member of the LC/DC 
lineage. Immunoelectronmicroscopic experiments supported this 
conclusion because the majority of FCERIa+ cells-although de-
void ofBirbeck granules - have a folded, or even indented, nucleus, 
a high number of mitochondria and endo-/lysosomal structures, a 
moderately well-developed Golgi apparatus, and a rough endoplas-
matic reticulum, and fail to exhibit granules specific for basophils or 
eosinophils (Fig 5) [22] . 
Table IV. Leukocyte Differentiation Antigens Expressed on 
Different Cell Types (percentage ± SD) 
Dermal 
Dendrocytes 
(FXIIIa+) 
91% ± 13% KiM8+ 
ND' 
• ND, not determined. 
Macrophages 
(KiM8+) 
44% ± 17% FXIIIa+ 
18% ± 6% RFD1+ 
Interdigitating Cells 
(RFD1+) 
ND 
50% ± 25% KiM8+ 
Figure 5. Ultrastructural characterization of 15-1+ non-mast cells within 
the human dermis, processing. a preembedding immunogold technique. 
FCERIa-beanng cells exhibit either long and spindle-shaped cytoplasmic 
dendntes or short and blunt cell processes (A,C). They have an indented, or 
even folded, nucleus that may occasionally appear segmented (A). Within 
their cytoplasm these cells contain large numbers of endo-/lysosomal struc-
tures (A). Most 15-1+ non-mast cells are localized in close proximity to 
blood vessels (C). Band D show in higher magnification the areas indicated 
by brackets in A and C: note that FCERIa, as indicated by MoAb 15-1 and 
5-nm gold particles, is uniformly expressed on the entire surface of the 
dendritic cells (arrows). DC, dendritic cell; EC, endothelial cell; L, lumen. 
Magnifications: A, X 17,000; bar, 0.5 IlIll. B: X 30,000; bar, 0.25 J1.m. C: 
X 7,000; bar, 1 J1.m. D: X 20,000; bar, 0.3 J1.m. 
This study therefore demonstrates that a major portion of dermal 
FCERIa-beanng, non-mast cells belong to the LC/DC lineage. 
Whether these cells are in transit to or from the epidermis or shun 
the epidermis entirely has yet to be answered. Romani et al [23] 
found that LC, cultured for 2-4 d, strongly react with MoAb 
RFDl. Because cultured LC resemble lymphoid DC in many other 
phenotypic and functional aspects, one may assume that dermal 
FC.ERIa+ /RFD 1 + cells represent LC emigrating from the epider-
mis. On the other hand, our observation that cytokine-activated LC 
rapidly downregulate FCERla (Maurer et ai, unpublished observa-
tion) contradict this argumentation. 
Concerning the possible function of FCERI it should be remem-
bered that patients with hyperimmunoglobulinemia E (24] , in par-
ticular atopic dermatitis patients [25], have a distribution pattern of 
IgE+ cells similar to that of FCERla+ cells observed in our studies 
([1], this study). This is compatible with the view that FCERla is the 
major IgE-binding structure in this disease. If this should be the 
case, crosslinking of IgE by antigens may be followed by receptor-
mediated transmembrane signaling resulting in either secretion of 
various soluble factors and/or internalization of the antigens fol-
lowed by antigen processing and presentation and, finally, by an 
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elicitation of a major histocompatibility complex - restricted im-
mune response [26]. If further investigations should confirm these 
speculations, interference with the FceRI could be a mechanism for 
the suppression of allergic skin diseases. 
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